Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Ureteral Neoplasms 2 Carcinoma, Transitional Cell 2 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Renal Pelvis and Ureter Urothelial Carcinoma 1 Recurrence 1 Disease 1 Carcinoma 1

Interventions

Blood Specimen Collection 9 Surveys and Questionnaires 6 Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Cyclophosphamide 6 Prednisone 5 Mammography 5 Colonoscopy 5 Biopsy 5 Positron Emission Tomography Computed Tomography 4 Magnetic Resonance Imaging 4 Lenalidomide 4 Biopsy, Fine-Needle 4 pembrolizumab 3 Tomography, X-Ray Computed 3 Surgical Procedures, Operative 3 Melphalan 3 Liquid Biopsy 3 Interviews as Topic 3 Exercise 3 Diagnostic Tests, Routine 3 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3 weifuchun 2 obinutuzumab 2 fluciclovine F-18 2 daratumumab 2 carfilzomib 2 Urination 2 Preoperative Exercise 2 Positron-Emission Tomography 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Disease × Nephroureterectomy × Clear all

NCT06169436 2023-12-13

Translational Cancer Observational Protocol

IRCCS San Raffaele

Disease, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡